drugset / Trial / NCT01190553

Pilot Study of Maintenance Therapy With Intravenous AMANTADINE

NCT01190553

Unknown 20 enrolled Rabin Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a pilot study for Maintenance Intravenous Treatment with AMANTADINE in patient with PARKINSON'S Disease who are not well balanced with medical treatment.

Timeline

Start
2010-11
Primary completion
2011-12
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Amantadine Unknown 200 mg Intravenous

Indications